Adbry 150 mg/mL prefilled syringe Images
Generic Name: tralokinumab
This medication has been identified as Adbry 150 mg/mL prefilled syringe. It is supplied by LEO Pharma Inc.
Adbry is used in the treatment of Atopic Dermatitis and belongs to the drug class interleukin inhibitors. Adbry 150 mg/mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Adbry
- Generic Name
- tralokinumab
- Strength
- 150 mg/mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- LEO Pharma Inc.
- National Drug Code (NDC)
- 50222-0346
More about Adbry (tralokinumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
